ID: ALA5278700

Max Phase: Preclinical

Molecular Formula: C14H13N3OS

Molecular Weight: 271.35

Associated Items:

Representations

Canonical SMILES:  CCCc1nc2c(NC=O)nc3ccccc3c2s1

Standard InChI:  InChI=1S/C14H13N3OS/c1-2-5-11-17-12-13(19-11)9-6-3-4-7-10(9)16-14(12)15-8-18/h3-4,6-8H,2,5H2,1H3,(H,15,16,18)

Standard InChI Key:  BYQWQEDCJGWEDQ-UHFFFAOYSA-N

Associated Targets(Human)

Toll-like receptor 8 1853 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 271.35Molecular Weight (Monoisotopic): 271.0779AlogP: 3.37#Rotatable Bonds: 4
Polar Surface Area: 54.88Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.69CX Basic pKa: CX LogP: 3.32CX LogD: 3.32
Aromatic Rings: 3Heavy Atoms: 19QED Weighted: 0.74Np Likeness Score: -0.92

References

1. Kaushik D, Kaur A, Petrovsky N, Salunke DB..  (2021)  Structural evolution of toll-like receptor 7/8 agonists from imidazoquinolines to imidazoles.,  12  (7.0): [PMID:34355178] [10.1039/D1MD00031D]

Source